Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CombiMatrix To Present at UBS Warburg Global Sciences Conference.


Business Editors/Health & Medical Writers

BIOWIRE2K

PASADENA, Calif.--(BW HealthWire)--Oct. 2, 2001

Acacia acacia (əkā`shə), any plant of the large leguminous genus Acacia, often thorny shrubs and trees of the family Leguminosae (pulse family).  Research Corporation (Nasdaq:ACRI) announced today that its majority-owned subsidiary majority-owned subsidiary

A firm in which more than 50% of outstanding voting stock is owned by the parent company.
, CombiMatrix Corporation, will be presenting at the UBS UBS Union Bank of Switzerland
UBS United Bible Societies
UBS United Blood Services
UBS United Buying Service
UBS Used Bookstore
UBS University Business Services
UBS Universal Building Society (UK)
UBS Ulaanbaatar Broadcasting System
 Warburg Global Life Sciences Conference in New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 at 10:40 a.m. on Oct. 9, 2001.

For more information on Acacia Research, visit the company's Web site at www.acaciaresearch.com.

About Acacia Research Corporation

Acacia Research develops and operates life science and enabling technology companies. The company's core technology opportunity has been developed through its subsidiary, CombiMatrix Corporation. Acacia Research intends to build and acquire companies in the life science and material science fields that will utilize CombiMatrix's biochip biochip

Small-scale device, analogous to an integrated circuit, constructed of or used to analyze organic molecules associated with living organisms. One type of theoretical biochip is a small device constructed of large organic molecules, such as proteins, and capable of
 technology. Acacia Research's website is located at www.acaciaresearch.com.

About CombiMatrix Corporation

CombiMatrix Corporation is developing a platform technology that allows the company to rapidly produce customizable active biochips, which are semiconductor-based tools for use in identifying and determining the physiological functions of genes, gene mutations Noun 1. gene mutation - (genetics) a mutation due to an intramolecular reorganization of a gene
point mutation

genetic science, genetics - the branch of biology that studies heredity and variation in organisms
 and proteins. This active biochip technology should provide for an enterprise-wide solution for pharmaceutical, biotechnology, and medical diagnostics companies to perform genomic and proteomic based research. CombiMatrix's website is located at www.combimatrix.com.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 2, 2001
Words:194
Previous Article:``Casper Spirit Dimensions,'' TDK'S Newest Game for the PlayStation 2 Ships to Stores; Casper Materializes in Retail Stores Just in Time for...
Next Article:Vista Research, Inc. Introduces Leak Detection Software To Conduct One-hour Tests on Underground Pipelines.
Topics:



Related Articles
BenefitPoint CEO to Speak at UBS Warburg Global Healthcare Services Conference.
CombiMatrix Presentation at UBS Warburg Conference Available Via Telephone.
SangStat to Present At UBS Warburg Global Life Sciences Conference.
TransForm Pharmaceuticals to Present At Two Industry Conferences.
Cell Pathways to Present at UBS Warburg Global Life Sciences Conference.
XOMA To Deliver Corporate Update at UBS Warburg Life Sciences Conference.
Acorda Therapeutics to Present at UBS Warburg Life Sciences Conference.
CombiMatrix to Present at the UBS Warburg Global Life Sciences Conference.
Transform Pharmaceuticals to Present at Two Industry Conferences.
Elusys Therapeutics to Present at UBS Warburg Global Life Sciences Conference on September 24, 2003.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles